biosimilar
USFDA Informs Biocon, Mylan Of Deferred Action On Biosimilar License Plea
Banking - Published date: .
Biocon said its arm, Biocon Biologics, and Mylan have been informed by the USFDA of a deferred action on the biologics l... Read more
Biocon's US Prospects Get A Boost After Company Receives EIR From USFDA
Banking - Published date: .
The insulin patent win, clearance of Malaysian unit and oncology biosimilar filing are triggers Read more